Yaokang Biotech said on July 21 it signed a strategic cooperation memorandum of understanding with South Korea clinical-trial sample-analysis firm GCCL. The partners will jointly offer integrated drug discovery and development services to global pharmaceutical and biotech companies, initially covering oncology and immunology and prioritising in vivo CAR‑T therapies.

2026-07-22

Yaokang Biotech said on July 21 it signed a strategic cooperation memorandum of understanding with South Korea clinical-trial sample-analysis firm GCCL. The partners will jointly offer integrated drug discovery and development services to global pharmaceutical and biotech companies, initially covering oncology and immunology and prioritising in vivo CAR‑T therapies.